<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-08-28T10:36:06Z</responseDate><request verb="GetRecord" identifier="oai:gredos.usal.es:10366/166971" metadataPrefix="mods">https://gredos.usal.es/oai/request</request><GetRecord><record><header><identifier>oai:gredos.usal.es:10366/166971</identifier><datestamp>2025-09-10T00:02:15Z</datestamp><setSpec>com_10366_149436</setSpec><setSpec>com_10366_3947</setSpec><setSpec>com_10366_3946</setSpec><setSpec>com_10366_3823</setSpec><setSpec>col_10366_151253</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Miranda-Vera, Carolina</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Hernández, Ángela Patricia</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>García-García, Pilar</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Díez, David</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>García, Pablo Anselmo</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Castro, María Ángeles</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2025-09-09T08:10:31Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2025-09-09T08:10:31Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2023</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="uri">http://hdl.handle.net/10366/166971</mods:identifier>
<mods:identifier type="doi">10.3390/pharmaceutics15122728</mods:identifier>
<mods:identifier type="essn">1999-4923</mods:identifier>
<mods:abstract>Podophyllotoxin is a naturally occurring cyclolignan isolated from rhizomes of Podophyllum sp.&#xd;
In the clinic, it is used mainly as an antiviral; however, its antitumor activity is even more interesting.&#xd;
While podophyllotoxin possesses severe side effects that limit its development as an anticancer agent,&#xd;
nevertheless, it has become a good lead compound for the synthesis of derivatives with fewer side&#xd;
effects and better selectivity. Several examples, such as etoposide, highlight the potential of this&#xd;
natural product for chemomodulation in the search for new antitumor agents. This review focuses on&#xd;
the recent chemical modifications (2017–mid-2023) of the podophyllotoxin skeleton performed mainly&#xd;
at the C-ring (but also at the lactone D-ring and at the trimethoxyphenyl E-ring) together with their&#xd;
biological properties. Special emphasis is placed on hybrids or conjugates with other natural products&#xd;
(either primary or secondary metabolites) and other molecules (heterocycles, benzoheterocycles,&#xd;
synthetic drugs, and other moieties) that contribute to improved podophyllotoxin bioactivity. In&#xd;
fact, hybridization has been a good strategy to design podophyllotoxin derivatives with enhanced&#xd;
bioactivity. The way in which the two components are joined (directly or through spacers) was also&#xd;
considered for the organization of this review. This comprehensive perspective is presented with&#xd;
the aim of guiding the medicinal chemistry community in the design of new podophyllotoxin-based&#xd;
drugs with improved anticancer properties.</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by-nc-nd/4.0/</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">Attribution-NonCommercial-NoDerivatives 4.0 Internacional</mods:accessCondition>
<mods:subject>
<mods:topic>podophyllotoxin; natural products; chemomodulation; hybrids; cytotoxicity</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>Podophyllotoxin: Recent Advances in the Development of Hybridization Strategies to Enhance Its Antitumoral Profile</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>